BCL2 and small cell lung carcinoma: The observed increase in caspase activation and cleavage of key apoptotic substrates reinforces the notion that co-targeting BCL-xL and BCL-2 for degradation induces a robust pro-apoptotic response in SCLC cells, ultimately leading to reduced cell viability.